Tag: sino biological

Table 1. Approved Therapies for Autoimmune Disease and Their Targets

Biotech & Life Sciences

Precision targeting of autoimmune diseases with Sino Biological

675-450

Biotech & Life Sciences

Influenza vaccine strains recommended by WHO (Northern Hemisphere)

Figure 1. Mechanism of Action of LEN

Biotech & Life Sciences

Sino Biological: Engineering the tools to outsmart HIV

Figure 1. Abnormal activation of protein tyrosine kinases (PTKs) in tumours. Proper PTK activation and inactivation are crucial for normal cellular function. Aberrant PTK activation is mediated by four major mechanisms: gain-of-function mutations, genomic amplifications, gene fusions and autocrine/paracrine ligand loops.

Biotech & Life Sciences

Kinase inhibitors: Overcoming resistance and enhancing clinical outcomes

Figure 1. Schematic of the various organoids that can be grown from PSCs and the developmental signals that are employed.

Biotech & Life Sciences

Cytokines in stem cells and organoids: A paradigm shift in drug discovery

Fig. 1 Bispecific ADC Examples: AZD9592 recognises EGFR and MET; M1231 recognises EGFR and MUC1; BL-B01D1 recognises EGFR and HER3.

Biotech & Life Sciences

New trends in ADC therapeutics: Expanding horizons and novel designs

Biotech & Life Sciences

Sino Biological and BioGeometry deepen partnership

Figure 2: Expression of full-length (left), truncated (middle), and methyltransferase plus ketoreductase domain fusion (right) constructs of human FASN. The full-length protein was prepared as reported by Hardwicke et al.(2014,doi:10.1038/nchembio.1603), whereas the domain fusion construct was prepared as reported by Lu et al.(2018, doi: 10.1016/j.bmcl.2018.05.014)

Biotech & Life Sciences

Cellular protein synthesis